March 5, 2024
Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston.
March 1, 2024
Brian Dean, MBA, MPH, a highly respected health care executive with more than 25 years of experience leading health systems across the country, joins UTHealth Houston as executive vice president for health affairs, effective March 18.
February 29, 2024
At just 9 years old, Lindsay Snyder was diagnosed with epilepsy in 2003. As she progressed through school, what Lindsay initially thought were “staring spells” in class turned out to be daytime seizures, and her nighttime seizures were even worse.
February 27, 2024
Three commitments to improve food security, diet quality, and health outcomes for vulnerable communities, made by UTHealth Houston in partnership with local and national organizations, have been approved as part of the White House Challenge to end Hunger and Build Healthy Communities.
February 23, 2024
In recognition of its expertise in treating SCN2A-related neurological disorders, UTHealth Houston has been designated as the first SCN2A Multidisciplinary Center by the FamilieSCN2A Foundation, the largest global advocacy organization for the group of disorders.
February 22, 2024
Lee Johnson, a healthy 65-year-old runner, was 200 yards from finishing his 10th half-marathon, when he suddenly collapsed with cardiac arrest just feet from crossing the Chevron Houston Marathon ribbon.
February 21, 2024
Across the United States, more babies born at 22 weeks’ gestation are admitted to neonatal intensive care units (NICUs) and surviving in increasing numbers, according to a new study led by UTHealth Houston.
February 19, 2024
UTHealth Houston is a national leader in National Institutes of Health (NIH) research funding, according to annual rankings released by the Blue Ridge Institute for Medical Research.
February 19, 2024
Three faculty members who have demonstrated longstanding excellence in areas of research, teaching, and clinical care, and a fourth recognized for overall exemplary dedication and service, received top honors from UTHealth Houston President Giuseppe N. Colasurdo, MD, Alkek-Williams Distinguished Chair, during a ceremony on Tuesday, Feb. 13.
February 15, 2024
“When you find something so precious, you want everyone to know.”
Those are the words from cervical cancer survivor, Juana Espino, who now serves as project coordinator of the Houston PAP Project. This UTHealth Houston program provides no-cost cervical cancer screenings to a predominantly Hispanic population. As a result of her journey, Espino has become instrumental in sharing her testimony and encouraging other Hispanic women to get screened.